glaucoma: Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
229 |
4. Check minimum number of eventsNone |
229 |
5. Include endpointsNone |
229 |
6. Filter based on genotype QC (FinnGen only) |
229 |
Control definitions (FinnGen only)
- Control exclude
- H7_GLAUCOMA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H40
- Name in latin
- Glaucoma [secundarium] posttraumaticum
Similar endpoints
↥List of similar endpoints to
Glaucoma secondary to eye trauma
based on the number of shared cases.
Similar with more cases:
- Glaucoma
- Diseases of the eye and adnexa
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2393 | 862 | 1511 |
| Only index persons | 2107 | 772 | 1335 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.02 | 0.04 |
| Only index persons | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 61.99 | 69.56 | 57.65 |
| Only index persons | 60.89 | 68.48 | 56.50 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 229 | 84 | 145 |
| Unadjusted period prevalence (%) | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | 61.20 | 58.27 | 62.89 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 203
- Matched controls
- 2030
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
16384.0
258.4
190
*
114
Kela drug reimbursment
Glaucoma
247.7
168.0
158
28
S01ED51
ATC
timolol, combinations; ophthalmic
229.6
159.6
151
25
S01EE01
ATC
latanoprost; ophthalmic
126.3
108.7
111
19
S01ED01
ATC
timolol; ophthalmic
116.7
97.6
101
17
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
+∞
91.8
81
*
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
445.0
86.9
81
*
S01EC04
ATC
brinzolamide; ophthalmic
245.8
79.5
77
5
H40.0
ICD-10 Finland
Glaucoma suspect
151.1
69.1
70
7
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
+∞
68.7
62
*
S01EC01
ATC
acetazolamide; systemic
68.7
61.3
69
15
S01EX03
ATC
NA
140.6
58.6
60
6
XCK00
NOMESCO Finland
Perimetry
27.0
52.4
74
42
S01EC03
ATC
dorzolamide; ophthalmic
131.5
40.5
42
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
9.3
36.2
86
148
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
6.9
35.9
139
485
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
+∞
35.5
33
*
S01EE05
ATC
tafluprost; ophthalmic
66.2
33.6
38
7
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
+∞
33.2
31
*
S01EE03
ATC
bimatoprost; ophthalmic
195.7
32.7
33
*
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
+∞
32.1
30
*
S01EE04
ATC
travoprost; ophthalmic
49.7
31.2
37
9
CHD00
NOMESCO Finland
Laser trabeculoplasty
+∞
25.5
24
*
S01ED02
ATC
betaxolol; ophthalmic
148.2
25.2
26
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
8.0
24.8
61
103
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
+∞
23.4
22
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.5
22.7
123
516
WX140
NOMESCO Finland
Parabulbar anesthesy
13.9
22.4
39
34
XCH00
NOMESCO Finland
Eye pressure measurement
22.1
22.1
32
17
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
16.6
21.8
35
25
3656E
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA POSTTRAUMATICUM]
+∞
21.2
20
*
S01EC54
ATC
brinzolamide, combinations; ophthalmic
122.6
21.0
22
*
XCK10
NOMESCO Finland
Photography of fundus of eye
6.7
20.6
57
111
H40.9
ICD-10 Finland
Glaucoma, unspecified
81.5
20.1
22
*
S01EB01
ATC
pilocarpine; ophthalmic
77.5
19.1
21
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
36.8
18.4
23
7
H26.1
ICD-10 Finland
Traumatic cataract
58.2
18.3
21
*
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
+∞
18.0
17
*
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
32.1
17.8
23
8
CHC05
NOMESCO Finland
Iridotomy
69.4
17.0
19
*
CHD99
NOMESCO Finland
Other filtering operation
+∞
16.9
16
*
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
25.7
16.8
23
10
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.6
16.3
103
451
37520
ICD-8 Finland
Glaucoma, Secondary
+∞
15.8
15
*
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
15.8
15
*
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
92.3
15.8
17
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
6.3
15.0
42
81
H27.0
ICD-10 Finland
Aphakia
161.0
14.7
15
*
S01EA02
ATC
dipivefrine; ophthalmic
+∞
13.7
13
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.8
13.6
49
127
S01EA03
ATC
apraclonidine; ophthalmic
30.7
13.2
17
6
XCH05
NOMESCO Finland
Eye pressure longterm registration
+∞
12.6
12
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.0
12.6
56
177
ZXA05
NOMESCO Finland
Left side
3.1
12.0
84
373
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
24.6
11.8
16
7
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
12.2
11.3
20
18
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
12.2
11.3
20
18
H40
ICD-10 Finland
Glaucoma
46.0
11.1
13
*
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
7.1
10.7
26
41
CHD35
NOMESCO Finland
Laser goniopuncture
+∞
10.5
10
*
H40.11
ICD-10 Finland
Low pressure glaucoma
+∞
10.5
10
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.7
10.4
36
88
S01BC03
ATC
diclofenac; ophthalmic
10.9
10.3
19
19
H26.4
ICD-10 Finland
After-cataract
4.2
10.0
40
113
ZXC20
NOMESCO Finland
Use of chemical agents
11.5
10.0
18
17
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
23.0
9.5
13
6
3610A
ICD-9 Finland
Retinal detachments and defects, Retinal detachment with retinal defect
+∞
9.4
9
*
H40.20
ICD-10 Finland
Acute glaucoma with closed ventricular angle
+∞
9.4
9
*
H40.8
ICD-10 Finland
Other glaucoma
+∞
9.4
9
*
S05.6
ICD-10 Finland
Penetrating wound of eyeball without foreign body
52.3
8.8
10
*
H18.1
ICD-10 Finland
Bullous keratopathy
52.3
8.8
10
*
H04.10
ICD-10 Finland
Dry eye syndrome
4.2
8.6
33
90
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
5.3
8.4
25
52
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
+∞
8.4
8
*
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
+∞
8.4
8
*
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
18.1
8.2
12
7
ZXD20
NOMESCO Finland
Day surgery
3.3
7.8
42
149
WX142
NOMESCO Finland
Sub-tenon anesthesy
46.8
7.8
9
*
CS494
NOMESCO Finland
Other visual field testing
19.3
7.7
11
6
CJF30
NOMESCO Finland
Reduction of dislocation of artificial lens
83.0
7.5
8
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
11.5
7.4
13
12
H25.1
ICD-10 Finland
Senile nuclear cataract
2.5
7.4
73
378
H44.5
ICD-10 Finland
Degenerated conditions of globe
+∞
7.3
7
*
CFW99
NOMESCO Finland
Other operation on conjunctiva
+∞
7.3
7
*
3708
FHL
Trabeculectomy or equivalent
+∞
7.3
7
*
3650A
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]
+∞
7.3
7
*
S01FA01
ATC
atropine; ophthalmic
31.2
7.2
9
*
H21.0
ICD-10 Finland
Hyphaema
41.5
6.8
8
*
CKD40
NOMESCO Finland
Endophotocoagulation of retina
12.8
6.7
11
9
H33.0
ICD-10 Finland
Retinal detachment with retinal break
6.6
6.6
16
26
37872
ICD-8 Finland
Other diseases of eye, Aphakia artefacta, acquisita
72.0
6.5
7
*
H57.1
ICD-10 Finland
Ocular pain
11.5
6.4
11
10
87091
ICD-8 Finland
Open wound of eye and orbit, Perforans oculi, Sequelae
+∞
6.3
6
*
F93
ICPC
Glaucoma
+∞
6.3
6
*
37405
ICD-8 Finland
Cataract, Traumatica
+∞
6.3
6
*
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
+∞
6.3
6
*
3643
FHL
Vitrectomy through pars Plana
+∞
6.3
6
*
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
27.6
6.3
8
*
W44
ICD-10 Finland
Foreign body entering into or through eye or natural orifice
8.1
6.2
13
17
H34.8
ICD-10 Finland
Other retinal vascular occlusions
7.1
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
0
+∞
5.22
1.8
0.0
ng/l
107.6
—
—
5
0
(3037467) Urinalysis macro (dipstick) panel - Urine
155
1202
1.90
4.82
5.2
4.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
121
897
1.74
4.10
9.6
6.9
mmol/l
1.2
1.2
0.22
105
757
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
200
1742
2.17
3.81
19.9
16.3
mg/l
25.8
25.8
0.00
166
1422
(3019550) Sodium [Moles/volume] in Serum or Plasma
206
1818
2.33
3.75
23.4
18.7
mmol/l
139.5
139.7
0.64
201
1767
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
84
577
1.72
3.65
3.2
2.6
u/l
52.3
55.8
0.56
74
532
(3023103) Potassium [Moles/volume] in Serum or Plasma
206
1825
2.28
3.60
23.8
18.8
mmol/l
4.0
4.0
0.24
200
1774
(3007853) Bacteria identified in Skin by Aerobe culture
39
214
1.99
3.45
2.0
1.8
—
—
—
0
0
(3019225) pH of Specimen
32
163
2.12
3.45
6.9
3.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
48
283
1.88
3.45
2.5
3.3
mmol/l
0.9
0.8
1.56
42
265
(42870588) Differential panel, method unspecified - Blood
80
557
1.67
3.24
6.2
5.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
121
938
1.61
3.17
7.4
6.5
umol/l
12.5
11.7
0.20
112
890
(3019309) Folate [Moles/volume] in Red Blood Cells
59
382
1.73
3.10
1.8
1.8
nmol/l
950.6
1259.8
2.00
43
294
(3012516) Albumin [Mass/volume] in Urine
79
554
1.65
3.09
4.0
3.1
mg/l
64.7
178.2
0.52
64
382
(3023368) Bacteria identified in Blood by Culture
80
569
1.62
2.94
5.2
4.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
210
1907
2.22
2.90
28.9
23.5
e9/l
7.0
6.8
0.60
204
1854
(3026361) Erythrocytes [#/volume] in Blood
210
1907
2.22
2.90
28.9
23.4
e12/l
4.4
4.5
0.29
203
1852
(3007461) Platelets [#/volume] in Blood
210
1907
2.22
2.90
28.8
23.4
e9/l
241.0
240.2
0.06
205
1860
(3026008) Bacteria identified in Urine by Culture
78
555
1.61
2.84
3.6
3.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
81
585
1.60
2.77
4.7
3.8
mg/mmol
18.0
10.8
0.36
58
389
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
311
1.73
2.75
1.8
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
102
783
1.55
2.65
19.3
9.0
inr
1.4
1.3
0.35
29
233
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
105
812
1.54
2.63
6.5
5.9
mmol/l
1.2
1.2
0.10
98
731
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
15
4.78
2.61
1.3
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
163
1392
1.59
2.59
9.5
7.6
u/l
85.4
80.0
0.61
152
1295
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
59
402
1.63
2.53
1.5
1.9
pmol/l
445.9
430.4
0.15
47
344
(3009508) Creatinine [Moles/volume] in Urine
77
568
1.54
2.34
4.4
3.0
mmol/l
7.1
7.8
0.72
68
477
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
65
468
1.54
2.19
2.6
2.0
mg/l
3.2
3.3
0.01
58
404
(3042936) Bacteria identified in Isolate by Culture
44
289
1.65
2.17
2.1
2.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
176
1559
1.56
2.11
4.3
4.4
mu/l
1.9
2.0
0.57
149
1389
(3002032) Base excess in Venous blood by calculation
30
180
1.77
2.04
10.5
4.3
mmol/l
3.3
1.6
0.70
25
144
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
57
2.36
2.01
1.5
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
22
121
1.91
1.96
1.8
1.5
—
—
—
0
0
(3012544) pH of Venous blood
30
183
1.74
1.94
10.6
4.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
33
207
1.69
1.93
1.4
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
100
804
1.43
1.91
7.0
6.2
%
9.0
8.7
0.43
93
747
(3006504) Eosinophils/100 leukocytes in Blood
99
798
1.42
1.85
6.9
5.9
%
3.0
2.8
0.24
92
738
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
11
47
2.41
1.80
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
74
2.10
1.79
1.5
1.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
12
54
2.29
1.77
6.3
7.1
mmol/l
1.1
1.3
0.43
12
47
(3012501) Base excess in Blood by calculation
9
36
2.56
1.76
6.6
2.8
mmol/l
3.6
2.2
—
9
21
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
68
2.13
1.74
1.4
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
101
824
1.40
1.74
7.2
6.1
%
25.1
26.6
0.78
95
761
(3022096) Basophils/100 leukocytes in Blood
96
777
1.41
1.73
7.1
5.8
%
0.6
0.6
0.08
89
715
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
13
3.91
1.72
5.0
2.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
99
811
1.39
1.64
6.8
5.9
%
59.4
58.2
0.46
94
757
(3013707) Erythrocyte sedimentation rate by Westergren method
149
1312
1.39
1.56
5.2
3.9
mm/h
16.0
13.2
0.84
138
1195
(3019060) Gas panel - Arterial blood
24
147
1.71
1.55
4.8
4.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
93
761
1.37
1.53
4.5
4.2
ng/l
93.5
44.1
0.47
71
562
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
198
1840
1.56
1.51
13.7
10.5
u/l
28.5
25.2
0.77
192
1764
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
585
1.39
1.49
3.9
3.3
mmol/l
2.3
2.3
0.02
61
515
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
126
1.73
1.46
1.3
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
184
1690
1.45
1.43
5.6
4.7
mmol/l
6.3
6.1
1.19
159
1539
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
90
743
1.35
1.37
2.0
2.0
pmol/l
94.6
93.1
0.11
45
402
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
81
660
1.35
1.34
2.4
2.2
nmol/l
78.8
77.3
0.16
74
580
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
32
220
1.53
1.33
1.9
1.9
—
—
—
0
0
(3010421) pH of Blood
9
43
2.14
1.32
6.6
2.9
ph
7.4
7.4
—
9
35
(3013512) EKG study
70
559
1.36
1.31
5.3
4.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
48
2.13
1.29
1.2
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
100
1.76
1.27
4.7
3.0
%
1.0
1.1
0.23
17
100
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
48
362
1.41
1.26
4.7
3.7
ng/l
119.7
178.7
0.27
37
300
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
99
838
1.32
1.25
4.9
4.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
224
1.50
1.23
1.8
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
167
1.56
1.18
1.4
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
72
1.85
1.17
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
66
532
1.34
1.16
4.4
4.4
ph
7.4
7.4
0.26
16
103
(3006315) Basophils [#/volume] in Blood
101
865
1.30
1.15
6.8
5.8
e9/l
0.0
0.0
0.19
88
745
(3013650) Neutrophils [#/volume] in Blood by Automated count
116
1012
1.30
1.15
10.8
9.4
e9/l
4.3
4.3
0.11
110
877
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
175
1619
1.34
1.09
8.3
6.2
mmol/mol
43.0
41.0
1.64
158
1502
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
32
2.22
1.09
5.7
3.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
32
2.22
1.09
1.7
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
92
784
1.29
1.07
7.9
4.8
g/l
34.3
35.0
0.56
87
737
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
101
872
1.28
1.06
5.6
5.1
ug/l
2.5
2.7
0.19
86
773
(3035285) Chloride [Moles/volume] in Venous blood
7
33
2.16
1.06
5.7
3.4
mmol/l
109.0
105.2
—
7
33
(3041354) Potassium [Moles/volume] in Venous blood
7
33
2.16
1.06
5.7
3.4
mmol/l
3.9
4.1
—
7
33
(40768804) Tissue Pathology biopsy report
80
671
1.30
1.05
2.3
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
50
393
1.35
1.03
4.5
5.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
36
268
1.41
1.03
3.4
2.7
%
19.6
22.7
0.73
28
233
(3019198) Lymphocytes [#/volume] in Blood
102
885
1.28
1.02
7.1
5.8
e9/l
1.8
1.9
0.28
92
784
(3013115) Eosinophils [#/volume] in Blood
103
895
1.27
1.02
6.9
5.9
e9/l
0.2
0.2
0.23
91
790
(3001122) Ferritin [Mass/volume] in Serum or Plasma
84
712
1.28
1.01
3.3
2.7
ug/l
134.1
161.2
0.69
76
655
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
35
2.03
1.01
1.3
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
25
174
1.49
1.00
3.0
2.7
ug/l
4.4
6.0
0.60
19
154
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
72
602
1.29
0.96
3.1
3.4
ng/l
1704.0
1832.2
0.11
64
522
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
9
51
1.80
0.95
1.3
1.1
g/l
0.3
0.2
—
9
51
(3024928) Oxygen saturation in Venous blood
7
37
1.92
0.95
3.3
3.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
59
482
1.30
0.94
3.3
2.8
umol/l
18107.7
7585.1
0.38
44
410
(3009542) Hematocrit [Volume Fraction] of Blood
163
1507
1.28
0.93
19.6
17.0
%
39.0
39.1
0.04
93
1011
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
105
926
1.25
0.89
2.9
2.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
173
1616
1.29
0.88
4.6
4.1
mmol/l
1.3
1.3
0.10
150
1479
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
47
376
1.31
0.87
1.3
1.7
mg/l
2.2
1.3
0.52
38
295
(3003396) Base excess in Arterial blood by calculation
32
241
1.38
0.87
4.3
6.8
mmol/l
1.5
1.2
0.17
26
189
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
82
705
1.25
0.86
5.3
4.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
45
1.81
0.85
3.9
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
98
862
1.24
0.84
6.9
5.7
e9/l
0.6
0.6
0.70
86
740
(1616796) Gas panel - Central venous blood
8
46
1.77
0.83
5.8
2.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
156
1.45
0.82
5.1
3.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
32
1.90
0.82
1.3
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
8
47
1.73
0.81
4.6
2.0
mg/l
9.4
15.0
—
8
42
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
135
1233
1.23
0.80
3.6
3.7
pmol/l
14.8
14.9
0.13
115
1095
(3021901) Oxygen saturation in Capillary blood
8
48
1.69
0.79
3.9
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
48
1.69
0.79
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
26
0.00
0.79
0.0
3.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
177
1667
1.27
0.78
5.1
4.5
mmol/l
1.3
1.4
1.80
157
1531
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
53
1.73
0.76
1.3
1.2
g/l
1.2
1.1
—
9
53
(3035350) Ketones [Presence] in Urine by Test strip
98
870
1.22
0.75
4.9
3.9
estimate
0.0
0.0
0.00
23
172
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
178
1680
1.27
0.75
5.1
4.6
mmol/l
4.4
4.5
0.38
160
1554
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
24
2.11
0.75
1.8
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
182
1723
1.27
0.75
5.8
5.1
mmol/l
2.6
2.7
0.17
163
1581
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
79
687
1.23
0.74
5.2
4.6
%
23.0
21.3
0.39
37
355
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
14
92
1.56
0.74
1.8
2.0
ug/l
0.9
1.5
—
9
86
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
275
1.32
0.74
1.1
1.2
iu/ml
29.3
36.4
—
10
88
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
60
1.70
0.73
2.5
2.5
ug/min
95.0
72.8
—
5
38
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
26
1.94
0.71
3.8
5.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
20
144
1.43
0.71
2.7
3.7
mmol/l
1.9
1.9
0.01
13
104
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
58
1.57
0.70
1.3
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
41
1.73
0.70
1.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
41
1.73
0.70
1.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
43
1.65
0.67
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
28
1.80
0.66
1.0
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
97
870
1.20
0.66
6.8
5.4
estimate
0.0
0.0
0.00
23
170
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
44
1.61
0.65
1.0
1.4
—
3.3
—
0
11
(3000764) Benzodiazepines [Presence] in Urine
5
29
1.74
0.64
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
51
598
0.81
0.63
4.0
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
27
210
1.32
0.62
1.2
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
50
1.62
0.62
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
30
1.68
0.62
1.4
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
30
1.68
0.62
1.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
50
423
1.23
0.60
2.5
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
97
1.47
0.60
7.1
8.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
22
0.00
0.59
0.0
2.1
—
4.6
—
0
5
(1761482) Bacteria [#/volume] in Urine by Culture
10
64
1.59
0.59
5.1
6.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
12
81
1.51
0.58
1.1
1.2
u/ml
72.8
310.2
1.88
12
73
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
31
249
1.28
0.58
1.1
1.3
u/ml
36.8
16.7
0.32
11
93
(21494755) Public health laboratory ask at order entry panel
8
122
0.64
0.56
1.3
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
37
1.64
0.56
1.0
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
232
1.29
0.56
6.4
8.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
97
883
1.17
0.53
5.0
3.9
estimate
0.0
0.0
0.00
23
159
(3037756) Immunofixation for Serum or Plasma
6
39
1.55
0.53
2.0
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
234
1.27
0.53
4.6
4.6
%
28.5
31.7
0.63
21
161
(3044640) Blood type and Crossmatch panel - Blood
64
564
1.19
0.52
2.6
2.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
12
84
1.45
0.50
3.6
2.1
u/l
39.9
38.2
0.13
12
75
(3029937) Albumin [Presence] in Urine by Test strip
57
499
1.19
0.50
5.3
4.0
estimate
0.0
0.0
0.00
23
158
(3000991) Gas panel - Venous blood
20
155
1.32
0.48
10.5
8.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
48
1.47
0.47
1.3
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
49
1.44
0.46
1.9
1.2
nmol/l
0.7
0.9
—
7
40
(40761511) CBC panel - Blood by Automated count
187
1804
1.20
0.46
21.0
15.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
57
503
1.18
0.45
4.8
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
50
1.41
0.45
1.0
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
20
157
1.30
0.45
2.3
2.3
g/l
0.2
0.2
0.39
20
145
(3022145) Colonoscopy Study observation
15
195
0.75
0.43
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
31
1.63
0.43
1.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
31
1.63
0.43
1.4
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
15
0.00
0.41
0.0
1.1
—
9.9
—
0
5
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
23
187
1.26
0.41
1.4
2.2
ug/g
104.7
129.8
0.29
16
151
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
60
1.35
0.40
1.0
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
61
1.32
0.40
3.9
2.2
kpa
8.3
8.0
—
8
51
(3021440) Promyelocytes/100 leukocytes in Blood
18
142
1.29
0.40
4.7
4.7
%
0.0
0.2
—
6
52
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
19
0.00
0.39
0.0
3.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
161
1.27
0.38
1.8
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
25
207
1.23
0.38
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
98
1.35
0.38
1.7
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
112
0.70
0.38
2.8
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
37
1.36
0.37
1.4
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
33
283
1.19
0.37
46.2
25.7
inr
1.6
1.4
0.25
13
34
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
71
1.28
0.36
1.9
2.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
135
1.28
0.36
3.6
4.8
%
0.0
0.2
—
6
44
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
171
1650
1.14
0.35
19.1
14.8
ml/min/173m2
72.2
76.8
1.50
141
1344
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
44
1.37
0.34
1.0
1.4
—
2.9
—
0
8
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
45
1.34
0.34
1.5
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
155
1.25
0.33
4.5
4.5
%
0.2
0.8
—
6
57
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
88
0.67
0.33
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
83
770
1.12
0.33
13.3
10.2
e9/l
0.0
0.0
0.50
71
633
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
230
1.20
0.33
1.8
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
39
344
1.16
0.32
1.3
1.2
u/ml
0.5
1.7
—
9
99
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
35
307
1.17
0.31
3.5
2.9
e6/l
1.9
1.1
0.49
22
192
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
222
1.19
0.31
2.1
1.8
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
7
56
1.26
0.29
4.9
4.4
—
3.6
—
0
7
(4010399)
16
130
1.25
0.29
1.6
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
57
1.24
0.29
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
115
1095
1.10
0.27
3.5
3.2
u/l
79.0
51.9
0.82
102
1022
(3002385) Erythrocyte distribution width [Ratio]
146
1407
1.10
0.27
24.5
19.8
%
13.9
13.8
0.48
141
1387
(3022621) pH of Urine by Test strip
16
132
1.23
0.26
4.4
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
170
0.81
0.26
5.1
3.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
53
487
1.11
0.25
3.3
3.0
ug/l
0.8
0.8
0.04
36
314
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
115
1.23
0.24
1.6
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
200
1.17
0.23
3.9
3.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
94
0.74
0.23
3.7
3.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
40
1.26
0.22
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
101
0.78
0.21
2.6
2.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
34
307
1.13
0.21
1.9
1.9
s
29.9
29.4
0.24
34
299
(40768441) Liver Pathology biopsy report
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.3
—
85.0
—
0
11
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
81.0
—
0
11
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.1
—
8.5
—
0
10
(1617658) Protocol used for examination of sentinel lymph nodes
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
12
0.00
0.21
0.0
1.7
—
3.3
—
0
7
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
113
0.79
0.20
1.7
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
9
115
0.77
0.20
1.9
2.3
—
5.7
—
0
5
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
14
0.00
0.20
0.0
1.9
—
558.0
—
0
6
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
10.9
—
0
7
(3011397) Hemoglobin [Presence] in Urine by Test strip
43
396
1.11
0.20
4.9
3.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
14
164
0.84
0.19
3.5
2.8
g/l
64.8
66.5
0.58
14
145
(3018095) Leukocytes [#/volume] in Urine
70
663
1.08
0.18
4.5
3.8
e6/l
95.3
191.4
0.41
54
499
(3002179) Metamyelocytes/100 leukocytes in Blood
16
138
1.17
0.18
4.3
4.4
%
0.2
0.3
—
5
37
(4034850)
7
62
1.13
0.17
3.3
12.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
92
1.21
0.16
1.1
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
71
1.13
0.16
1.1
2.4
g/l
4.3
3.1
—
8
56
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
71
1.13
0.16
1.1
2.4
g/l
10.9
10.1
—
8
62
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
77
0.77
0.16
1.5
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
56
529
1.08
0.15
4.0
3.3
e6/l
0.8
0.6
0.17
44
404
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
21
188
1.13
0.15
1.7
1.6
—
—
—
0
0
(4035726)
14
160
0.87
0.14
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
84
1.20
0.14
1.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
103
1.17
0.14
1.0
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
97
0.82
0.14
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
132
1.15
0.13
3.2
2.5
—
—
—
0
0
(3020891) Body temperature
10
85
1.18
0.12
6.1
4.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
44
1.14
0.10
1.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
106
1.14
0.10
2.6
3.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
54
1.11
0.09
1.5
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
126
1237
1.04
0.08
4.9
4.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
45
431
1.05
0.08
1.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
78
1.03
0.07
1.1
2.3
g/l
4.4
3.8
—
8
55
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
78
1.03
0.07
1.1
2.3
g/l
9.3
7.5
—
8
58
(3043409) Potassium [Moles/volume] in Arterial blood
8
78
1.03
0.07
2.1
3.6
mmol/l
4.0
4.0
—
8
69
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
78
1.03
0.07
1.1
2.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
68
697
0.97
0.06
4.3
3.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
45
435
1.04
0.06
1.7
1.6
nmol/l
18.0
20.0
0.40
37
366
(36304419) Bacteria [Presence] in Urine
51
495
1.04
0.05
3.7
3.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
12
111
1.09
0.04
1.3
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
60
588
1.03
0.03
4.2
3.4
e6/l
70.4
209.5
0.66
48
467
(3000492) Spirometry study
15
142
1.06
0.02
1.7
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
31
319
0.97
0.02
2.1
1.4
g/l
2.2
2.5
0.57
20
190
(3019832) Treponema pallidum Ab [Presence] in Serum
11
103
1.07
0.02
2.3
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
107
0.93
0.02
5.6
5.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
36
352
1.03
0.02
3.1
3.0
mmol/l
2.5
2.4
0.73
29
309
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
177
0.96
0.01
1.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
40
393
1.02
0.01
6.2
4.2
kg/l
1.0
1.0
—
8
60
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
10
98
1.02
0.00
3.8
8.8
mmol/l
24.2
24.6
—
10
93
(40758558) Short blood count panel - Blood
42
424
0.99
0.00
8.7
6.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
44
437
1.01
0.00
1.7
1.6
mmol/l
1.3
1.4
0.26
36
360
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
292
0.99
0.00
3.6
3.1
e6/l
0.7
1.9
1.26
16
180
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
95
1.06
0.00
1.8
2.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
53
0.94
0.00
1.4
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
3.1
—
13.2
—
0
7
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.3
—
559.1
—
0
7
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
3.3
—
91.9
—
0
8
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.8
—
75.9
—
0
8
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
60
1.00
0.00
1.2
2.5
g/l
31.6
37.4
—
6
50
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
4.9
—
103.4
—
0
7
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
84
0.95
0.00
4.3
3.1
u/ml
30.6
599.1
—
8
70
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
132.2
—
0
5
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.3
—
0.6
—
0
6
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_GLAUCSECTRAUMA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_GLAUCSECTRAUMA | 1.083 [0.92, 1.27] | 0.327 |
| Birth year | 0.994 [0.99, 1.0] | 0.134 |
During the follow-up period (1.1.1998 — 31.12.2019), 277 out of 736 females with H7_GLAUCSECTRAUMA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_GLAUCSECTRAUMA | 1.166 [0.99, 1.37] | 0.061 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 310 out of 1144 males with H7_GLAUCSECTRAUMA died.
Mortality risk
Mortality risk for people of age
years, who have H7_GLAUCSECTRAUMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.096% | 0.217% |
| 5 | 0.64% | 1.213% |
| 10 | 1.766% | 3.075% |
| 15 | 3.328% | 5.942% |
| 20 | 5.542% | 9.904% |
Relationships between endpoints
↥Index endpoint: H7_GLAUCSECTRAUMA – Glaucoma secondary to eye trauma
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data